Abeona Therapeutics (ABEO) EBIT (2011 - 2026)
Abeona Therapeutics (ABEO) recorded quarterly EBIT of -$23.0 million in Q1 2026, down 128.26% quarter-over-quarter from $81.5 million in Q4 2025, and down 16.76% on a YoY basis from -$27.7 million in Q1 2025.
Abeona Therapeutics (ABEO) EBIT (2011 - 2026) Analysis & Trends
Abeona Therapeutics' EBIT history runs 16 years deep, the most recent figure standing at -$23.0 million for Q1 2026.
- In Q1 2026, EBIT fell 16.76% year-over-year to -$23.0 million; the TTM figure through Mar 2026 stood at $11.7 million (up 116.76% YoY), while the FY2025 annual figure was $15.0 million, up 123.31% from the prior year.
- EBIT was -$23.0 million for Q1 2026 at Abeona Therapeutics, down from $81.5 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $81.5 million in Q4 2025 to a low of -$24.0 million in Q3 2025.
- Historically, EBIT has averaged -$10.0 million across 5 years, with a median of -$14.3 million in 2024.
- The sharpest annual moves came in 2024 and 2025: EBIT tumbled 69.26% in 2024, then soared 588.89% in 2025.
- A 5-year view of EBIT shows it stood at -$12.9 million in 2022, then declined by 2.11% to -$13.2 million in 2023, then declined by 26.22% to -$16.7 million in 2024, then jumped by 588.89% to $81.5 million in 2025, then tumbled by 128.26% to -$23.0 million in 2026.
- The last three EBIT figures came in at -$23.0 million (Q1 2026), $81.5 million (Q4 2025), and -$24.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -65.83 Mn |
| 10 | Abeona Therapeutics | 309.15 Mn | 140.88 Mn | 6.02 Mn | -23.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.03 Mn |
| Dec 31, 2025 | 81.51 Mn |
| Sep 30, 2025 | -24.02 Mn |
| Jun 30, 2025 | -22.79 Mn |
| Mar 31, 2025 | -19.73 Mn |
| Dec 31, 2024 | -16.67 Mn |
| Sep 30, 2024 | -15.35 Mn |
| Jun 30, 2024 | -17.86 Mn |
| Mar 31, 2024 | -14.33 Mn |
| Dec 31, 2023 | -13.21 Mn |
| Sep 30, 2023 | -11.33 Mn |
| Jun 30, 2023 | -10.55 Mn |
| Mar 31, 2023 | -12.04 Mn |
| Dec 31, 2022 | -12.94 Mn |
| Sep 30, 2022 | -9.38 Mn |
| Jun 30, 2022 | -8.01 Mn |
| Mar 31, 2022 | -20.59 Mn |
| Dec 31, 2021 | -46.65 Mn |
| Sep 30, 2021 | -14.87 Mn |
| Jun 30, 2021 | -13.72 Mn |